Other metabolic pathway-related differences involved differences between c8 and c1—both enriched for BLCA cases, with c1 showing evidence for higher levels of fatty acid synthesis pathway (Fig. 5a and Supplementary Fig. 5a). The gene discussed is CDCA3; the disease is bladder transitional cell carcinoma.